When 20 μg/mL of mannan was added to the DC-SIGN-mediated trans-infection assay to act as a competitive inhibitor, trans-infection was decreased to about 10% for all non-Omicron strains: wild-type = 8.16%, D614G = 6.15%, Delta = 9.96%. The gene discussed is CD209; the disease is infection.